vs

Side-by-side financial comparison of Atara Biotherapeutics, Inc. (ATRA) and Digital Brands Group, Inc. (DBGI). Click either name above to swap in a different company.

Digital Brands Group, Inc. is the larger business by last-quarter revenue ($1.6M vs $1.6M, roughly 1.0× Atara Biotherapeutics, Inc.). On growth, Digital Brands Group, Inc. posted the faster year-over-year revenue change (-25.1% vs -95.1%). Over the past eight quarters, Digital Brands Group, Inc.'s revenue compounded faster (-33.0% CAGR vs -75.9%).

Atara Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on developing allogeneic T-cell immunotherapies for patients with unmet medical needs across oncology, autoimmune disease, and infectious disease indications. It operates primarily in North America, Europe, and Asia-Pacific, partnering with research institutions to advance its novel treatment pipeline.

Fortune Brands Innovations, Inc. is an American manufacturer of home and security products, headquartered in Deerfield, Illinois. Its portfolio of businesses and brands includes Moen and the House of Rohl; outdoor living and security products from Therma-Tru, Larson, Fiberon, Master Lock and SentrySafe; and MasterBrand Cabinets. Fortune Brands is a Fortune 500 company and part of the S&P 400 Index. As of December 31, 2021, the company reported employing approximately 28,000 associates and pos...

ATRA vs DBGI — Head-to-Head

Bigger by revenue
DBGI
DBGI
1.0× larger
DBGI
$1.6M
$1.6M
ATRA
Growing faster (revenue YoY)
DBGI
DBGI
+70.0% gap
DBGI
-25.1%
-95.1%
ATRA
Faster 2-yr revenue CAGR
DBGI
DBGI
Annualised
DBGI
-33.0%
-75.9%
ATRA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATRA
ATRA
DBGI
DBGI
Revenue
$1.6M
$1.6M
Net Profit
$-20.6M
Gross Margin
-77.1%
Operating Margin
-1385.4%
Net Margin
-1283.8%
Revenue YoY
-95.1%
-25.1%
Net Profit YoY
73.2%
-283.4%
EPS (diluted)
$0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATRA
ATRA
DBGI
DBGI
Q4 25
$1.6M
$1.6M
Q3 25
$3.5M
$1.7M
Q2 25
$17.6M
$2.3M
Q1 25
$98.1M
$1.9M
Q4 24
$32.8M
$2.1M
Q3 24
$40.2M
$2.4M
Q2 24
$28.6M
$3.4M
Q1 24
$27.4M
$3.6M
Net Profit
ATRA
ATRA
DBGI
DBGI
Q4 25
$-20.6M
Q3 25
$-4.3M
$-3.5M
Q2 25
$2.4M
$-2.1M
Q1 25
$38.0M
$-2.1M
Q4 24
$-12.7M
$-5.4M
Q3 24
$-21.9M
$-3.5M
Q2 24
$-19.0M
$-3.5M
Q1 24
$-31.8M
$-683.7K
Gross Margin
ATRA
ATRA
DBGI
DBGI
Q4 25
-77.1%
Q3 25
42.7%
Q2 25
31.6%
Q1 25
46.6%
Q4 24
-35.3%
Q3 24
46.0%
Q2 24
45.9%
Q1 24
48.1%
Operating Margin
ATRA
ATRA
DBGI
DBGI
Q4 25
-1385.4%
Q3 25
-103.5%
-201.3%
Q2 25
18.2%
-88.2%
Q1 25
39.5%
-106.7%
Q4 24
-37.3%
-230.1%
Q3 24
-54.1%
-112.4%
Q2 24
-63.7%
-67.8%
Q1 24
-114.2%
-6.3%
Net Margin
ATRA
ATRA
DBGI
DBGI
Q4 25
-1283.8%
Q3 25
-124.6%
-208.7%
Q2 25
13.6%
-94.1%
Q1 25
38.7%
-111.7%
Q4 24
-38.8%
-250.7%
Q3 24
-54.5%
-145.1%
Q2 24
-66.5%
-103.4%
Q1 24
-116.1%
-19.1%
EPS (diluted)
ATRA
ATRA
DBGI
DBGI
Q4 25
$0.73
Q3 25
$-0.32
$-1.18
Q2 25
$0.19
$-0.81
Q1 25
$3.50
$-0.92
Q4 24
$0.27
$132.02
Q3 24
$-2.93
$-81.53
Q2 24
$-3.10
$-104.18
Q1 24
$-5.65
$-23.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATRA
ATRA
DBGI
DBGI
Cash + ST InvestmentsLiquidity on hand
$8.5M
$1.9M
Total DebtLower is stronger
$6.1M
Stockholders' EquityBook value
$-38.5M
$8.8M
Total Assets
$20.2M
$44.5M
Debt / EquityLower = less leverage
0.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATRA
ATRA
DBGI
DBGI
Q4 25
$8.5M
$1.9M
Q3 25
$13.7M
$6.7M
Q2 25
$22.3M
$542.6K
Q1 25
$13.8M
$2.2M
Q4 24
$42.5M
$164.4K
Q3 24
$67.2M
$289.3K
Q2 24
$35.3M
$92.8K
Q1 24
$46.2M
$11.3K
Total Debt
ATRA
ATRA
DBGI
DBGI
Q4 25
$6.1M
Q3 25
Q2 25
Q1 25
Q4 24
$6.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ATRA
ATRA
DBGI
DBGI
Q4 25
$-38.5M
$8.8M
Q3 25
$-36.6M
$16.0M
Q2 25
$-35.0M
$7.1M
Q1 25
$-55.1M
$6.2M
Q4 24
$-97.3M
$-1.3M
Q3 24
$-90.5M
$19.0K
Q2 24
$-110.9M
$2.7M
Q1 24
$-98.3M
$3.0M
Total Assets
ATRA
ATRA
DBGI
DBGI
Q4 25
$20.2M
$44.5M
Q3 25
$30.2M
$41.2M
Q2 25
$36.9M
$27.8M
Q1 25
$62.0M
$27.2M
Q4 24
$109.1M
$19.9M
Q3 24
$142.7M
$23.3M
Q2 24
$117.3M
$24.9M
Q1 24
$165.3M
$24.8M
Debt / Equity
ATRA
ATRA
DBGI
DBGI
Q4 25
0.70×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATRA
ATRA
DBGI
DBGI
Operating Cash FlowLast quarter
$-50.9M
$-4.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATRA
ATRA
DBGI
DBGI
Q4 25
$-50.9M
$-4.7M
Q3 25
$-9.8M
$-5.1M
Q2 25
$-7.3M
$-1.6M
Q1 25
$-28.1M
$-4.5M
Q4 24
$-24.5M
$-2.8M
Q3 24
$-4.0M
$-541.6K
Q2 24
$-10.6M
$-1.6M
Q1 24
$-29.6M
$-1.2M
Free Cash Flow
ATRA
ATRA
DBGI
DBGI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-24.6M
Q3 24
$-541.6K
Q2 24
$-10.7M
$-1.6M
Q1 24
$-29.7M
$-1.3M
FCF Margin
ATRA
ATRA
DBGI
DBGI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-75.0%
Q3 24
-22.2%
Q2 24
-37.3%
-47.9%
Q1 24
-108.7%
-35.1%
Capex Intensity
ATRA
ATRA
DBGI
DBGI
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.0%
Q4 24
0.3%
Q3 24
0.0%
0.0%
Q2 24
0.1%
0.3%
Q1 24
0.5%
0.4%
Cash Conversion
ATRA
ATRA
DBGI
DBGI
Q4 25
Q3 25
Q2 25
-3.07×
Q1 25
-0.74×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons